42C — IX Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for IX Biopharma, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.21	13.5	6.53	1.84	0.866
Net Total Accounts Receivable
Net Total Receivables	1.82	1.98	3.05	2.92	1.94
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.35	16.8	11	6.59	4.21
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.95	7.72	8.22	7.61	6.72
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	18.9	28.5	24.9	14.6	11.3
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.67	7.86	7.17	7.38	8.98
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	7.15	8.77	9.08	10.3	10.9
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11.7	19.7	15.9	4.34	0.365
Total Liabilities & Shareholders' Equity	18.9	28.5	24.9	14.6	11.3
Total Common Shares Outstanding